FTO and nonpapillary renal cell carcinoma: Besides, Zhang et al. investigated that activation of FTO induced by an increased intracellular α-ketoglutarate–to-succinate ratio could stabilize BRD9 to assemble super enhancers to drive tumor growth of HIF2αlow/− ccRCC [17].